HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael L Sabolinski Selected Research

Isosorbide Dinitrate (Isordil)

8/2012Effect of fixed-dose combined isosorbide dinitrate/hydralazine in elderly patients in the African-American heart failure trial.
11/2009Dysfunctional corin i555(p568) allele is associated with impaired brain natriuretic peptide processing and adverse outcomes in blacks with systolic heart failure: results from the Genetic Risk Assessment in Heart Failure substudy.
11/2008Exploring the potential synergistic action of spironolactone on nitric oxide-enhancing therapy: insights from the African-American Heart Failure Trial.
8/2007Evidence for the continued safety and tolerability of fixed-dose isosorbide dinitrate/hydralazine in patients with chronic heart failure (the extension to African-American Heart Failure Trial).
6/2007Isosorbide dinitrate and hydralazine in a fixed-dose combination produces further regression of left ventricular remodeling in a well-treated black population with heart failure: results from A-HeFT.
4/2007Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial.
1/2007Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American Heart Failure Trial.
1/2007Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial.
12/2006Outcomes by gender in the African-American Heart Failure Trial.
12/2005Cost-effectiveness of fixed-dose combination of isosorbide dinitrate and hydralazine therapy for blacks with heart failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael L Sabolinski Research Topics

Disease

12Heart Failure
08/2012 - 12/2005
5Wounds and Injuries (Trauma)
01/2020 - 05/2014
3Leg Ulcer
03/2018 - 05/2014
2Systolic Heart Failure
11/2009 - 11/2008
1Osteomyelitis
01/2019
1Ulcer
01/2019
1Diabetic Foot
01/2019
1Ventricular Remodeling
06/2007
1Renal Insufficiency (Renal Failure)
12/2006
1Hypertension (High Blood Pressure)
09/2006

Drug/Important Bio-Agent (IBA)

10Isosorbide Dinitrate (Isordil)FDA LinkGeneric
08/2012 - 12/2005
10Hydralazine (Apresoline)FDA LinkGeneric
08/2012 - 12/2005
3CollagenIBA
01/2019 - 05/2014
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
11/2008 - 01/2007
1Collagen Type I (Type I Collagen)IBA
01/2020
1polihexanideIBA
01/2020
11- (1- phenylcyclohexyl)- 3- methylpiperidine (PCMP)IBA
01/2020
1Brain Natriuretic Peptide (Natrecor)FDA Link
11/2009
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
04/2009
1Angiotensin Receptor AntagonistsIBA
11/2008
1Mineralocorticoid Receptor AntagonistsIBA
11/2008
1Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2008
1Spironolactone (Aldactone)FDA LinkGeneric
11/2008
1AngiotensinsIBA
06/2007
1ReninIBA
06/2007
1DiureticsIBA
06/2007
1Digoxin (Digitek)FDA LinkGeneric
06/2007
1Vasodilator Agents (Vasodilators)IBA
06/2007
1CreatinineIBA
12/2006
1Hemoglobins (Hemoglobin)IBA
12/2006
1Cytochrome P-450 CYP11B2 (CYP11B2)IBA
09/2006

Therapy/Procedure

6Therapeutics
05/2017 - 12/2005
1Artificial Skin
01/2019
1Surgical Amputation (Amputations)
01/2019
1Biological Therapy
03/2018
1Length of Stay
12/2005